Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2578717 | Thérapie | 2015 | 5 Pages |
Abstract
Among the observational studies of drug effects in chronic diseases, many of them have found effects that were exaggerated or wrong. Among bias responsible for these errors, the immortal time bias, concerning the definition of exposure and exposure periods, is relevantly important as it usually tends to wrongly attribute a significant benefit to the study drug (or exaggerate a real benefit). In this article, we define the mechanism of immortal time bias, we present possible solutions and illustrate its consequences through examples of pharmacoepidemiological studies of drug effects.
Keywords
HDLCSIBPCOGPRDPharmacoépidémiologieTHsBiasesbronchopneumopathie chronique obstructiveimmortal time biasrisque relatifBiaisPharmacoepidemiologyhigh density lipoproteinétude de cohorteCohort studiestraitement hormonal substitutifGeneral Practice Research DatabaseDatabasesBases de donnéesCorticostéroïdes inhalés
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Jean-Luc Faillie, Samy Suissa,